Skip to content

REDPHARMA

Active Public limited companyfounded 2010active for 16 yearsDa Vincilaan 7, 1930 ZaventemKBO/BCE: BE 0824.819.011 subsidiary of IQVIA Solutions Belgium#7 company by staff growth in Flemish Brabant, Advertising and market research sector
Part of the group IQVIA HOLDINGS INC. 8 companies in 2 countries
See the group
REDPHARMA
Follow ReportCompare

Board

3 directors, 1 auditor, no change since May 2026

Deed of 07-05-2026Permanent representative: Peter LenoirReappointment: Forvis Mazars Bedrijfsrevisoren BV (statutory auditor) · General meeting of 09-07-2025

Clotilde Ghysselinckx
Director
since 30-06-2022 term until 14-06-2028
listed in the 2025 annual accounts, filed on 13-07-2026
Clément Vanthournhout
Director
since 30-06-2022 term until 14-06-2028
listed in the 2025 annual accounts, filed on 13-07-2026
Emmanuel Vanderhaegen
Director
since 01-02-2023 term until 14-06-2028
listed in the 2025 annual accounts, filed on 13-07-2026
Forvis Mazars Réviseurs d’Entreprises
Statutory auditor, permanent representative Peter Lenoir
current term since 11-06-2025 term of 3 financial years from 2026
listed in the 2025 annual accounts, filed on 13-07-2026

Office holders in the KBO →

Mandates through the years

17 names, the dashed line is today
Show
Clotilde Ghysselinckx
Director
Clément Vanthournhout
Director
Emmanuel Vanderhaegen
Director
Forvis Mazars Réviseurs d’Entreprises
Statutory auditor
Frank Swaelens
Director
BENOVITY
Director
Bernard Marchant
Director
Pierre Nokin
Director
ROSSEL & Cie
Director
KPMG Réviseurs d'Entreprises BV/SRL
Statutory auditor
Noëlle LUCAS
Statutory auditor
STRATIFY
Director
BEAUVOIS Thierry
Director
Paul Moreau
Managing director
ZANCHETTA Martin Antoine Daniel
Managing director
MOREAU Paul Alexandre
Managing director
Patrick Hermans
Manager
BoardEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
  • Clotilde Ghysselinckx
    • Director, from 30-06-2022 to date
  • Clément Vanthournhout
    • Director, from 30-06-2022 to date
  • Emmanuel Vanderhaegen
    • Director, since before 31-12-2022
  • Forvis Mazars Réviseurs d’Entreprises
    • Statutory auditor, appointed by deed of 07-09-2022, still in office
  • Frank Swaelens
    • Director, appointed by deed of 24-08-2022, until 13-02-2023
  • BENOVITY
    • Director, appointed by deed of 02-05-2018, until 24-08-2022
    • Managing director, appointed by deed of 02-05-2018, ended, last mentioned on 02-05-2018
  • Bernard Marchant
    • Chair of the board, appointed by deed of 02-05-2018, ended, last mentioned on 02-05-2018
    • Director, appointed by deed of 02-05-2018, until 24-08-2022
  • Pierre Nokin
    • Chair, appointed by deed of 27-06-2013, ended, last mentioned on 27-06-2013
    • Director, appointed by deed of 27-06-2013, until 24-08-2022
  • ROSSEL & Cie
    • Director, appointed by deed of 02-05-2018, until 24-08-2022
  • KPMG Réviseurs d'Entreprises BV/SRL
    • Statutory auditor, from 30-07-2021, no longer listed in the 2025 annual accounts
  • Noëlle LUCAS
    • Statutory auditor, appointed by deed of 16-08-2019, until 13-01-2022
  • STRATIFY
    • Director, appointed by deed of 02-05-2018, until 21-12-2018
  • BEAUVOIS Thierry
    • Director, until 16-08-2017
  • Paul Moreau
    • Manager, until 10-02-2011
    • Director, until 16-08-2017
    • Managing director, until 16-08-2017
  • ZANCHETTA Martin Antoine Daniel
    • Manager, appointed by deed of 21-04-2010, until 10-02-2011
    • Manager, appointed by deed of 06-12-2011, until 27-06-2013
    • Director, appointed by deed of 27-06-2013, until 16-08-2017
    • Managing director, appointed by deed of 27-06-2013, until 16-08-2017
  • MOREAU Paul Alexandre
    • Manager, from 06-04-2010, last mentioned in 2013
    • Managing director, appointed by deed of 27-06-2013, last mentioned in 2013
  • Patrick Hermans
    • Manager, appointed by deed of 29-07-2011, until 01-10-2011

Control

Parent
IQVIA Solutions Belgium
Equity €17.2m
Profit €1.8m in 2025 (profit €985,045 in 2024)
Checked score 83
100%
This company
REDPHARMA
Equity €1.4m
Profit €2.2m in 2025

Further up the chainIQVIA AG 99.99%IQVIA Holding INC. consolidates

and 1 other shareholder

Capital

Capital
€93,600
Shares
37,744 in the 2023 annual accounts
Contribution per share
€2.48
Equity per share
€35.98 in 2025
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
IQVIA Solutions Belgium
100%
100%
IQVIA Holding INC.
consolidates
consolidates
ROSSEL & Cie
76.78%
76.78% until 2021
Owners as a list

Source: shareholder structure in its own accounts, parent in its own accounts, lists of holdings in the owners' accounts

Articles of association

deed of 26-08-2022 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 3 directors
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Second Wednesday of June at 10:00
Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
“Algemene vergadering kan te allen tijde beperken bij gewone meerderheid, aandeelhouders verdelen liquidatiesaldo met gelijkheidsbeginsel”

Shareholders

2 owners

Owners 2

Capital transactions

Shareholders according to the deeds
After 2 capital increases deed of 27-06-2013 ↗
  • Pierre NOKIN 833 shares · in cash
  • SA Beaufagne 1,667 shares · in cash
Stated in the deed deed of 27-06-2013 ↗
At incorporation deed of 21-04-2010 ↗
Capital over time
  1. 26-08-2022 Capital stated in the deed · 37,744 shares
  2. 27-06-2013 Capital increase of €6,200 · to €24,800 · 2,500 new shares
  3. 27-06-2013 Capital increase of €68,800 · to €93,600 · no new shares · from reserves
  4. 21-04-2010 Incorporation · €18,600 · 186 shares

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure